Daporinad (Compound)

Synonyms:Daporinad, 658084-64-1, FK866, FK-866, APO-866, APO866, FK 866, 201034-75-5, Daporinad [INN], APO 866, (E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide, (E)-N-(4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL)-3-(PYRIDIN-3-YL)ACRYLAMIDE, FK866 hydrochloride hydrate, V71TF6V9M7, C24H29N3O2, N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide, K 22.175, 1198425-96-5, (E)-Daporinad, (2E)-N-(4-(1-Benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)prop-2-enamide, (2E)-N-[4-(1-Benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide, FK-866 HCl, (E)-N-[4-(1-Benzoyl-piperidin-4-yl)-butyl]-3-pyridin-3-yl-acrylamide, 2gvj, (2e)-N-{4-[1-(Benzenecarbonyl)piperidin-4-Yl]butyl}-3-(Pyridin-3-Yl)prop-2-Enamide, UNII-V71TF6V9M7, DGB, FK866 (APO866), 4o1b, 4o1d, Daporinad (APO866), DAPORINAD [WHO-DD], CHEMBL566757, Daporinad(FK866,APO866), GTPL7745, BDBM81395, CHEBI:94671, EX-A430, 2g97, CHEBI:187413, Daporinad (FK866, APO866), DTXSID101026050, BCP01909, FD5006, MFCD10565943, n-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2e-propenamide, NSC760442, NSC777194, s2799, AKOS015994576, N-[4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL]-3-(PYRIDIN-3-YL)PROP-2-ENAMIDE, BCP9000687, CCG-208012, DB12731, ES-0047, NSC 751605, NSC-760442, NSC-777194, NCGC00182868-04, A850039, A930135, EN300-24106674, BRD-K58550667-001-01-2, Q27076984, (E)-N-[4-[1-(benzoyl)piperidin-4-yl]butyl]-3-pyridin-3-ylprop-2-enamide, 2-Propenamide, N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-, 2-PROPENAMIDE, N-(4-(1-BENZOYL-4-PIPERIDINYL)BUTYL)-3-(3-PYRIDINYL)-, (2E)-, FK 866;(E)-N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide, Nicotinamide Phosphoribosyltransferase Inhibitor, FK866 - CAS 658084-64-1

Id:6914657

Description:nan